Patent application number | Description | Published |
20090169635 | PHARMACEUTICAL COMPOSITIONS AND USE THEREOF - Colloidal compositions, loaded with non-covalently bonded antibiotics, can be efficiently used for the treatment of severe bacterial pneumonia and other serious lung infections such as tuberculosis. Such formulations, comprised of biodegradable nanoparticles or nanocapsules with incorporated antibiotics, show a significant increase in antibacterial activity, extended and sustained drug release and a decrease in frequency of the drug administration. Antibiotics of various types, such as aminoglycosides, glycopeptides and others can be successfully incorporated into a nanoparticulate colloidal delivery system. | 07-02-2009 |
20100099775 | METHOD FOR AMELIORATING OF POST-ANESTHETIC RECOVERY - The invention describes use of injectable form of Idebenone to improve recovery after general anesthesia and of cognitive functions, suppress disorientation and other signs of neuronal damage. | 04-22-2010 |
20100129431 | IDEBENONE COMPOSITION FOR THE TREATMENT OF NEUROLOGICAL DISORDERS - The invention describes the use of an injectable form of Idebenone to induce protect from neuronal damage, improve recovery after brain trauma; stroke, intoxication, neurodegenerative diseases, memory loss or neuropathology associated with neuroinflammation or infection damage and to restore cognitive function, suppress disorientation, alcoholic and drug abuse associated syndromes and other signs of neuronal damage. | 05-27-2010 |
20100130619 | PHARMACEUTICAL COMPOSITION FOR PARENTERAL ADMINISTRATION OF IDEBENONE - The invention describes use of an injectable form of Idebenone, suitable for intravenous injection or infusion. The proposed formulation is an oil-in-water emulsion, where Idebenone is associated with the oil droplets. | 05-27-2010 |
20100215725 | PHARMACEUTICAL COMPOSITION CONTAINING IDEBENONE FOR THE TREATMENT OF LIVER DISORDERS - The invention describes the use of an injectable form of Idebenone to protect against hepatic damage, improve recovery from liver trauma, poisoning, vapor intoxication, degenerative diseases, hepatocyte function loss and pathology associated with inflammation or infection. The use of injectable Idebenone restores liver function, suppresses elevated enzyme levels, decreases alcoholic and drug abuse associated syndromes, symptoms of acute hepatitis of various origins, the consequences of liver reperfusion and other signs of liver damage. | 08-26-2010 |
20110070305 | SUSTAINED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING MEBICAR - The invention relates to a sustained release pharmaceutical composition, containing mebicar, for the treatment of anxiety, depression and other psychiatric and neurological disorders. | 03-24-2011 |
Patent application number | Description | Published |
20080287532 | OXACYCLOPENTENE-2 DERIVATIVES - The present invention relates to oxacyclopentene-2 derivatives as compounds possessing antiinflammatory, neuroprotective, immunomodulatory and cardiovascular activities in mammals. | 11-20-2008 |
20090060993 | SOLID PHARMACEUTICAL COMPOSITION FOR ENHANCED DELIVERY OF COENZYME Q-10 AND UBIQUINONES - The present invention describes a solid oral dosage form of ubiquinones (e.g., ubidecarenone, coenzyme Q-10, idebenone or mixture thereof), providing on contact with water or body fluids the regulated release of an “in situ” formed oil-in-water emulsion with ubiquinone incorporated in the oil phase. Described formulation demonstrates improved bioavailability. | 03-05-2009 |
20090061009 | Composition and Method of Treatment of Bacterial Infections - The invention is intended for a treatment of severe infections using an injectable drug-delivery system comprising nanoparticles of a biodegradable polymer with incorporated antibacterial drug. | 03-05-2009 |
20090062244 | PHARMACEUTICAL COMPOSITION - Topical composition for enhanced local and systemic delivery of poorly soluble biologically active compounds, comprises of non-volatile solvent or mixture of solvents to dissolve active component, and moisture absorbent or mixture of sorbents to prevent precipitation or crystallization of insoluble material after application | 03-05-2009 |